Logo

Agendia

Agendia Building Validation Data on ImPrint for Guiding Neoadjuvant Immunotherapy in Breast Cancer
Premium

The firm envisions marketing the 53-gene signature with its existing MammaPrint and BluePrint tests as a comprehensive platform for breast cancer treatment selection.

People in the News: New Appointments at Agendia, Seegene, Illumina, More

Agendia Offering AI-Enabled Genomic Test for Breast Cancer in Brazil as it Eyes Global Market
Premium

The firm is offering access in Brazil to a digital assay that provides genomic insights using technology developed in a collaboration with computational pathology firm Paige.

Agendia to Distribute Inivata Liquid Biopsy Breast Cancer Test in North America, Europe

Agendia will receive co-exclusive rights to distribute Inivata's RaDaR assay for minimal residual disease and relapse detection in Europe and North America.

Agendia FLEX Registry Powers Genomics Research on Underrepresented Breast Cancer Patients
Premium

FLEX will include full transcriptome data paired with 800 data points from 10,000 patients, offering researchers the chance to study diverse patient subsets.

Nov 18, 2020

Agendia, Paige Partner to Codevelop New Assays Using MammaPrint, BluePrint Signatures

Oct 15, 2020

Germany Grants National Reimbursement for Three Additional Breast Cancer Biomarker Tests

Oct 6, 2020

PathoNext to Offer Agendia's Breast Cancer Recurrence Assays in Germany

Aug 26, 2020

Agendia's MammaPrint Breast Cancer Risk Test Cost-Effective in Multi-Country Analysis

Jul 2, 2020

Agendia Settles Allegations of Medicare Fraud for $8.25M

Jun 12, 2020

New Data Support Role of Agendia BluePrint Test in Refining Breast Cancer Subtypes
Premium

May 21, 2019

Agendia, Imegen Ink Distribution Deal for Breast Cancer Tests in Spain, Portugal

Dec 19, 2018

Breast Cancer Molecular Tests Included in Recommendations by UK's NICE

Dec 10, 2018

SABCS 2018 Features Molecular Diagnostics Research

Nov 16, 2018

Agendia Breast Cancer Tests Show Promise for Improved Therapy Prediction
Premium

Oct 10, 2018

NCCN Update on Breast Cancer Genetic Testing Guidelines Marks Oncotype DX as 'Preferred' Test

Sep 18, 2018

Agendia Partners With GeneCast to Launch Tests in China

Aug 24, 2018

In Brief This Week: MolecularMD, Agendia, Promega, NRGene, More

Jul 25, 2018

Agendia Secures $35M Investment

May 24, 2018

Agendia Inks Southeast Asian Marketing Deal for Breast Cancer Tests

May 15, 2018

Agendia Breast Cancer Tests Adopted by French Hospital Group

May 1, 2018

Aetna, Cigna, UnitedHealthcare to Cover Agendia's MammaPrint

Apr 5, 2018

Agendia Moving to Decentralized Testing Model in Europe, Exploring Options for Asia Expansion
Premium

Mar 21, 2018

Agendia NGS MammaPrint BluePrint Kit Receives CE Mark

Feb 7, 2018

UK's NICE Finalizing Updated Breast Cancer Test Guidance Following Stakeholder Comments
Premium

Breaking News
The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.